Investigator Initiated Observational Study of Intravitreal Aflibercept Injection in Subjects With Diabetic Macular Edema Previously Treated With Ranibizumab or Bevacizumab
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- Acronyms SwapTwo
- 29 Sep 2016 Planned End Date changed from 1 Feb 2017 to 1 Dec 2018.
- 29 Sep 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2018.
- 08 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.